by The Mount Sinai Hospital AMETA treatment effectively clumps the virus and disarms its spike structures, which are essential for infecting host cells. Credit: Jialu Xu, Ph.D., University of Oxford. Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling...
Category: <span>Virology</span>
Post
Protecting the family from seasonal respiratory infections
by Mayo Clinic News Network Credit: Pixabay/CC0 Public Domain Cold, flu, RSV and COVID-19 all have one thing in common: They are respiratory infections that cause similar symptoms such as coughing, fever and fatigue. These illnesses can range from mild to severe, especially in people who are more vulnerable. Dr. Tina Ardon, a family medicine...
Post
‘Two for the price of one’—scientists discover new process to drive anti-viral immunity
Artistic depiction of the discovery. Credit: Prof. Luke O’Neill’s lab, Trinity College Dublin. Scientists at Trinity College Dublin have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to new, effective therapies for people with...
Post
Over 160,000 new virus species discovered by AI
Largest discovery of new virus species sheds light on hidden virosphere Peer-Reviewed PublicationUniversity of Sydney Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every corner of the globe. 161,979 new species of RNA virus have been discovered using a...
Post
History of COVID-19 found to double long-term risk of heart attack, stroke and death
A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California. The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even...
Post
Study finds persistent infection could explain long COVID in some people
Brigham researchers have found that people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms. A persistent infection could explain why some people experience long COVID symptoms, according to a new study led by researchers at Brigham and Women’s Hospital. The team found...
Post
Q&A: Pathologist discusses another reason to vaccinate teens against HPV
Credit: Pixabay/CC0 Public Domain In 2006, a vaccine became available to protect against infections associated with two strains of the human papillomavirus (HPV). It was a potential game-changer: These strains cause 70% of cervical cancers, 90% of anal cancers, and about 75% of the cancers that affect the throat. Newer generations of this vaccine are generally recommended...
Post
COVID-19 increases chronic fatigue risk
New research shows that COVID-19 survivors, especially older adults and non-hospitalized patients, are at an increased risk for chronic fatigue syndrome—underscoring the need for comprehensive care for vulnerable populations. Study: Risk of chronic fatigue syndrome after COVID-19: A retrospective cohort study of 3227281 patients. Image Credit: DimaBerlin / Shutterstock In a recent study published in the Journal of Infection...
Post
Severe COVID-19 can involve either exacerbated lung inflammation or high viral replication, study finds
September 3, 2024 by Maria Fernanda Ziegler, FAPESP Lung autopsy tissue infected by SARS-CoV-2 with endothelial cells (red), active inflammasome (green) and SARS-CoV-2 RNA (pink), showing that the virus was replicating. Credit: Keyla de SáAccording to an article published in the journal PLOS Pathogens, severe COVID-19 patients can be divided into two distinct groups: those...
Post
Facts about LB.1, or D-FLiRT, the newest COVID subvariant
JULY 23, 2024 by Adrian Esterman, The Conversation Credit: Pixabay/CC0 Public DomainHeadlines are again warning of a new COVID variant in Australia. This time it’s LB.1, or as some experts have dubbed it, “D-FLiRT.” Emerging evidence suggests LB.1 could be more transmissible than earlier omicron subvariants, though there’s nothing to suggest it will cause more...